Reducing unnecessary medications in elderly patients with multiple prescriptions
Official title: Patient-centred Deprescribing of Psychotropic, Sedative and Anticholinergic Medication in Elderly Patients With Polypharmacy: a Cluster-randomised Trial
Run by Ludwig-Maximilians - University of Munich · NCT05842928 · Data updated 2026-11-12
This study tests a new way to help older adults with multiple prescriptions cut down on unnecessary medications by working closely with their doctors and pharmacists.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 352 (estimated) |
| Sponsor | Ludwig-Maximilians - University of Munich Academic / other |
| Locations | 3 sites (Bielefeld and 2 other locations) |
| Status | Recruiting |
| Started | March 25, 2023 |
| Main results expected | April 2026 |
| Study ends | October 2026 |
| Registry record updated | May 4, 2025 |
| Trial ID | NCT05842928 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are elderly patients aged 65 and older who are currently taking five or more medications, including at least one potentially inappropriate medication.
✕Probably not a fit
Patients with terminal illnesses, severe physical or mental health conditions, or those unable to participate in the study due to their health status may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The PARTNER study evaluates a patient-centered approach to reduce the use of potentially inappropriate medications among elderly patients who are taking multiple drugs. It involves collaboration between general practitioners and community pharmacists to provide education, workshops, and shared decision-making processes. Participants will receive a comprehensive medication review and empowerment strategies to manage their prescriptions effectively. The study compares this intervention to a control group that only receives a basic medication review.
Why it matters
Potential benefit: If successful, this approach could significantly improve medication safety and quality of life for elderly patients by reducing the risks associated with polypharmacy.
How similar studies have gone: Other studies have shown success in similar approaches to deprescribing and medication management in elderly populations, indicating a promising avenue for improving patient outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 65 years or older * Patient is capable of giving consent * GP contact in the quarter prior to inclusion * Current use of ≥ 5 drugs, including ≥ 1 PSA-PIM (hypnotics, opioids, gabapentinoids, antipsychotics, antidepressants, anticholinergic urospasmolytics) with a treatment duration of ≥ 6 months * Willingness to select a regular pharmacy for the study period * Consent to data exchange between GP and community pharmacy Exclusion Criteria: * Terminal illness (life expectancy \< 6 months) * Current treatment of pain associated with cancer * Other serious physical illness or mental distress (e.g. bereavement) that makes participation in the study impossible (according to the GP's assessment) * Psychiatric illness or addiction that makes participation in the study impossible (according to the GP's assessment) * Unable to meet the requirements of the study (participation in telephone or written questionnaires, visits to the GP practice or community pharmacy, alone or with the help of caregivers for physical infirmity) * Current participation in research projects on medication safety or geriatric medicine
Where it's running
-
University Hospital, LMU Munich
Munich, Germany Recruiting -
University of Bielefeld
Bielefeld, Germany Not yet recruiting -
Witten/Herdecke University
Witten, Germany Not yet recruiting
Study contacts
- Principal investigator: Tobias Dreischulte, Prof. Dr. — Institute of General Practice and Family Medicine, University Hospital, LMU Munich, Munich, Germany
- Study coordinator: Tobias Dreischulte, Prof. Dr.
- Email: tobias.dreischulte@med.uni-muenchen.de
- Phone: +49 89 4400 55447
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Quality of Recovery after opioid-free vs opioid-based general anesthesia in major urological surgery
This trial tests whether opioid-free anesthesia leads to a better recovery score, as measured by QoR-15, in adults undergoing major urological surgery compared to anesthesia with remifentanil.
-
Improving pain control for children on breathing machines
This trial tests whether giving IV acetaminophen and/or IV ketorolac can reduce pain and the need for opioids in children aged 2 months to 17½ years who are on mechanical ventilation for acute respiratory failure.
-
Different spinal morphine doses for pain relief after hip replacement
This trial tests whether different doses of morphine given with spinal anesthesia reduce pain and balance safety after total hip replacement in adults.
-
Nebulized ketamine treatment for major depression in hospitalized patients
This study is testing if breathing in ketamine can help people with moderate to severe depression feel better while they are in the hospital.
-
Opioid-free anesthesia for abdominal surgery
This study is testing whether using an opioid-free anesthesia for abdominal surgery can help patients feel less pain and have fewer side effects compared to traditional anesthesia that includes opioids.
-
Identifying predictors for treatment response in major depression
This study is trying to find out what factors can help predict how well different treatments will work for people with major depression.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.